Tradestie Institutional Equity Comparison Engine
EVGN vs KMDA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KMDA Overall Edge
KMDA Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kamada Ltd (KMDA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EVGN trades at N/M Forward P/E with -858.2% operating margin (-60.7% YoY revenue) versus KMDA at 14.1x Forward P/E and 15.4% operating margin (+10.7% YoY). In options structure, EVGN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against KMDA sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
KMDA
EVGN N/M vs KMDA 14.1x Fwd P/E
Growth & Margin Winner
KMDA
Op Margin -858.2% vs 15.4% ยท YoY -60.7% vs +10.7%
Momentum & Technical Winner
KMDA
1Y -71.9% vs +16.7% ยท 52W Pos 9% vs 57%
Options & Structure Winner
KMDA
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (50th %ile IV)
EVGN
NASDAQ
Evogene Ltd.
Agricultural Chemicals
$0.34
-13.17% 1D
Market Cap
$6.0M
1M Return
-7.58%
1Y Return
-71.89%
Forward P/E
N/M
Unified AI Score
44.1 / 100
HOLD
Tech 42.0
Fund 44.0
Flow 50.0
Mom 60.0
KMDA
NASDAQ
Kamada Ltd
Pharmaceutical Preparations
$8.16
+0.62% 1D
Market Cap
$468.2M
1M Return
+7.23%
1Y Return
+16.74%
Forward P/E
14.1x
Unified AI Score
42.7 / 100
HOLD
Tech 28.0
Fund 46.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EVGN -71.89%
KMDA +16.74%
Spread: +88.63 pp (KMDA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
EVGN TTM Op. Margin: -858.2%
KMDA TTM Op. Margin: 15.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVGN vs KMDA. Trailing 12-month operating profitability (EVGN -858.2% vs KMDA 15.4%) and valuation multiples (EVGN N/M vs KMDA 14.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EVGN | KMDA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.0M | $468.2M | Larger Scale | KMDA |
| Trailing P/E Ratio Valuation | N/M | 21.3x | Lower Multiple | KMDA |
| Forward P/E Ratio Valuation | N/M | 14.1x | Lower Multiple | KMDA |
| Revenue Growth (YoY) Growth | -60.7% | +10.7% | Higher Growth | KMDA |
| Operating Margin (TTM) Profitability | -858.2% | 15.4% | Higher Margin | KMDA |
| Net Profit Margin Profitability | 0.0% | 12.7% | Higher Margin | KMDA |
| Return on Equity (ROE) Capital Efficiency | -182.8% | 9.3% | Higher ROE | KMDA |
| 52-Week Range Position Momentum | 9% ($0โ$1) | 57% ($7โ$9) | Stronger Trend | KMDA |
| Beta / 30D Volatility Risk Regime | 1.37ฮฒ ยท 138% Vol | 0.96ฮฒ ยท 50% Vol | Lower Realized Risk | KMDA |
| Unified Institutional Score Composite Signal | 44.1 / 100 (HOLD) | 42.7 / 100 (HOLD) | Higher Composite | EVGN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EVGN vs KMDA Buy Guide
EVGN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
KMDA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
50th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EVGN nor KMDA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.